✦ LIBER ✦

Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience

✍ Scribed by A. OUSSALAH; C. LACLOTTE; J.-B. CHEVAUX; M. BENSENANE; A. BABOURI; A.-A. SERRE; T. BOUCEKKINE; X. ROBLIN; M.-A. BIGARD; L. PEYRIN-BIROULET

Book ID: 108605437
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 103 KB
Volume: 28
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2008.03811.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab for Crohn’s disease with into

Adalimumab for Crohn’s disease with intolerance or lost response to infliximab: a 3-year single-centre experience

✍ A. OUSSALAH; A. BABOURI; J.-B. CHEVAUX; L. STANCU; I. TROUILLOUD; M. BENSENANE; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Treatment of ulcerative colitis with ada

Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort

✍ N. Gies; K. I. Kroeker; K. Wong; R. N. Fedorak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Efficacy and safety of short-term adalim

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

✍ J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB